🔴 AIM ImmunoTech is trading 5% down today as weak markets pressure growth stocks

AIM ImmunoTech is trading at $0.16, down 5.06%, with broad market weakness appearing to weigh on growth stocks.

• No clear company-specific announcement surfaced for October 14; the recent company coverage found was published October 7.
• September CPI exceeded expectations, while the S&P 500 and Nasdaq are down, pressuring growth stocks.
• Biotech-sector declines may add pressure, though available evidence points more strongly to broad market sentiment than to a specific AIM ImmunoTech catalyst.